CaseVuCategory Archives: Press Releases
Precipio Announces Q3-2023 Shareholder Update Call
Conference Call to be held on November 20th, 2023 at 5:00 PM EST NEW HAVEN, [...]
Nov
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022
28% Revenue Increase is Major Step toward Company Breakeven NEW HAVEN, CT, Globenewswire – (October [...]
Oct
Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023
Company anticipates current cash levels sufficient to reach breakeven NEW HAVEN, CT, Globenewswire – (October [...]
Oct
Precipio Continues to Sign New HemeScreen™ Customers
New customer orders received in Q3 exceed $1M annualized revenue NEW HAVEN, CT, Globenewswire – [...]
Sep
Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven
Higher pathology revenues and lower cost structure drive down product revenue breakeven point from $8M [...]
Sep
Precipio Takes Final Step Towards Regaining Nasdaq Compliance
Company announces 1-for-20 reverse stock split NEW HAVEN, CT – (September 21, 2023) – Specialty [...]
Sep
Precipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan
Company continues to make strides towards profitability NEW HAVEN, CT, Globenewswire – (September 13, 2023) – [...]
Sep
Precipio Announces Q2-2023 Shareholder Update Call
Conference Call to be held on August 17, 2023 at 5:00 PM EST NEW HAVEN, [...]
Aug
Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel
Advanced panel already generating six-figure pre-orders NEW HAVEN, CT, Globenewswire – (August 8, 2023) – Specialty [...]
Aug
Precipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven
Revenue growth and customer pipeline advance the Company towards breakeven NEW HAVEN, CT, Globenewswire – [...]
Aug